1.72
                                            전일 마감가:
              $1.73
            열려 있는:
              $1.76
            하루 거래량:
                56,485
            Relative Volume:
              0.23
            시가총액:
                $134.80M
            수익:
              -
            순이익/손실:
              -
            주가수익비율:
              -
            EPS:
                -
            순현금흐름:
                -
            1주 성능:
              +0.00%
            1개월 성능:
              -15.27%
            6개월 성능:
                +98.11%
            1년 성능:
              +45.15%
            Citius Oncology Inc Stock (CTOR) Company Profile
명칭
                  
                      Citius Oncology Inc
                    
                전화
                  
                      (908) 967-6677
                    
                주소
                  
                      11 COMMERCE DRIVE, CRANFORD
                    
                CTOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
|   
                          
                                CTOR
                            
                             Citius Oncology Inc | 1.72 | 144.48M | 0 | 0 | 0 | 0.00 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 143.47 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.38 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.24 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.09 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 442.65 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-09-23 | 업그레이드 | Maxim Group | Hold → Buy | 
| 2024-11-27 | 개시 | Maxim Group | Buy | 
Citius Oncology Inc 주식(CTOR)의 최신 뉴스
Building trade automation scripts for Citius Oncology Inc.Weekly Trading Summary & Stock Portfolio Risk Management - newser.com
Regression analysis insights on Citius Oncology Inc. performanceMarket Volume Report & Detailed Earnings Play Strategies - newser.com
Predicting Citius Oncology Inc. trend using moving averagesMarket Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
Why retail investors favor Citius Oncology Inc. stockQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com
Real time social sentiment graph for Citius Oncology Inc.2025 Market Sentiment & Community Consensus Trade Alerts - newser.com
What the charts say about Citius Oncology Inc. todayTrade Volume Report & Weekly Market Pulse Updates - newser.com
What data driven models say about Citius Oncology Inc.’s futureAnalyst Downgrade & Weekly Watchlist for Hot Stocks - newser.com
News impact scoring models applied to Citius Oncology Inc.2025 Short Interest & Reliable Price Action Trade Plans - newser.com
How Citius Oncology Inc. stock benefits from strong dollarJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-29 00:05:52 - newser.com
Published on: 2025-10-28 05:08:21 - newser.com
Is Citius Oncology Inc. stock a buy on dipsM&A Rumor & Weekly High Momentum Picks - Fundação Cultural do Pará
What high frequency data says about Citius Oncology Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com
Is Citius Oncology Inc. stock attractive for long term wealth buildingAnalyst Upgrade & Community Verified Watchlist Alerts - newser.com
Citius Oncology Stockholders Approve Share Increase - TipRanks
Citius Oncology Inc (CTOR) 재무 분석
        Citius Oncology Inc (CTOR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
    
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):
                 
            
         
                     
                             Stockscreener 앱 받기
                    Stockscreener 앱 받기